In healthcare marketing the approval chain, not the creative work, usually sets the launch date. Drawing on our delivery work for a multi-location US healthcare group, where reviews set the pace more than capacity did, this post covers the stages to expect, how to schedule them and a claim-level log.
What the healthcare engagement showed
We delivered the work as a dedicated pod inside a US agency’s own tools, for the agency’s multi-location healthcare client. The agency’s backlog was the reason we were brought in, so the obvious assumption was that more delivery capacity would set the pace.
It did not. The approval chain did. In healthcare, the people who approve marketing are compliance officers, legal counsel and sometimes a medical director, for whom marketing review is one part of a much broader job. Their queue competes with clinical and legal priorities that reasonably come first.
The lesson we took from it, recorded in the healthcare delivery case study: a plan built around delivery throughput rather than approval throughput will miss its dates, however fast the work is produced.
Our first 2 weeks were also slower than either side wanted, for a related reason. Working inside someone else’s tools, conventions and client history takes a real ramp.
- 1Was every claim-bearing sentence marked in the brief and first draft, in week one?NoMark them now, not at final review
- 2Are claims that need a clinical source routed now, in parallel with creative?NoRoute them: substantiation is usually the slowest stage
- 3Is a reviewer named for each stage, with cover when they are away?NoName them: four reviewers sit in four queues
- 4Is review its own named phase, with a buffer sized to real turnaround?NoSize it to your organisation, not an industry average
- 5Do you count claims approved, approved with edits and still open each week?NoThe date follows that count, not the creative
Four reviewers, four queues
Not every organisation runs all four, and some combine them. Treating them as one “final approval” step is the most common planning mistake, because they sit with different people with different queues.
| Stage | Usually done by | What it checks | When to route it |
|---|---|---|---|
| Claims substantiation | Compliance, with a clinical contact | Every statement about outcomes, efficacy or comparison has a documented basis | As soon as claim-bearing copy is drafted, in week one |
| Regulatory qualification | Compliance | Required disclaimers, licensing language and scope-of-practice wording are present and correct | Alongside the first full draft |
| Legal and risk | Legal counsel | Liability exposure, separate from the compliance question | Once claims are settled, before design is final |
| Clinical sign-off | A clinician or medical director | Accuracy of any health statement | In parallel with creative, never at the end |
Claims substantiation is usually the slowest, because finding a source a compliance reviewer can check often means going back to a clinical contact rather than the marketing team. It is the most common cause of a missed launch date, and the most avoidable.
Plan in approval throughput, not delivery throughput
This is the order we would use on any healthcare campaign now. It costs little at the start and saves the scramble at the end.
- In week one, mark every sentence in the brief and first draft that makes a claim. Claim-bearing copy is found at the start, not at final review.
- Route claims that need a clinical source immediately, in parallel with creative development.
- Name each reviewer for each stage, and who covers when they are away.
- Put review in the timeline as its own named phase with its own buffer, sized to your organisation’s real turnaround, not an industry average.
- Each week, count claims approved, approved with edits, and still open. The launch date follows that count, not the state of the creative.
Our healthcare work runs on the same principle: nothing carrying a clinical claim publishes without sign-off from the client’s side, and data handling, consent and analytics decisions are documented for the compliance officer to approve before anything ships.
The claim log
The simplest tracker that works is one row per claim, not one row per asset. A single landing page can carry several claims, each needing a different reviewer and source. Tracking at page level is how an approved page still ships one sentence nobody signed off.
Illustrative rows, showing the fields rather than any client’s content:
| Claim as written | Asset | Evidence or source | Reviewer | Status |
|---|---|---|---|---|
| Same-week appointments at every clinic | Location pages | Booking system availability report | Operations, then compliance | Approved with edits |
| Treatment reduces recovery time | Service page | Clinical source requested | Medical director | Open, waiting on source |
| Rated highly by patients | Ad copy | Review platform data | Compliance | Rejected, needs rewrite |
The status field matters more than it looks. “Approved with edits” and “rejected, needs rewrite” call for different next actions, and done or not done hides whether the date is at risk.
The same idea, a check placed where a mistake would be public and hard to undo, runs through the approval steps we build into AI automation.
What this process is not
A claim log and a planned review phase make approval predictable. They do not make an agency your compliance function, and we do not claim to be one.
- We do not hold compliance certifications; for HIPAA there is no official vendor certification to hold.
- The decision on any claim stays with your compliance, legal and clinical reviewers. The log records their decisions; it does not replace them.
- For a single practice with one reviewer and little claim-bearing copy, a shared document with the same fields is enough. The full process earns its keep across several locations and reviewers.
Written by
Shweta Agarwal
Chief Operating Officer, Vinove
Shweta runs the operating side of the group, holding delivery, process and accountability consistent across the group. Her focus is on the systems that let teams grow without losing the standard they started with.
LinkedIn →
